SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Alessia Leone, Savino Sciascia, Ameer Kamal, Munther Khamashta, Biologicals for the treatment of systemic lupus erythematosus: current status and emerging therapies, Expert Review of Clinical Immunology, 2015, 11, 1, 109

    CrossRef

  2. 2
    Onur Boyman, Denis Comte, François Spertini, Adverse reactions to biologic agents and their medical management, Nature Reviews Rheumatology, 2014, 10, 10, 612

    CrossRef

  3. 3
    Mikkel Faurschou, David R.W. Jayne, Anti–B Cell Antibody Therapies for Inflammatory Rheumatic Diseases, Annual Review of Medicine, 2014, 65, 1, 263

    CrossRef

  4. 4
    Andrew E Nixon, Daniel J Sexton, Robert C Ladner, Drugs derived from phage display, mAbs, 2014, 6, 1, 73

    CrossRef

  5. 5
    Chi Chiu Mok, Emerging biological therapies for systemic lupus erythematosus, Expert Opinion on Emerging Drugs, 2014, 19, 2, 303

    CrossRef

  6. 6
    Yu Guo, Amr H. Sawalha, Qianjin Lu, Epigenetics in the treatment of systemic lupus erythematosus: Potential clinical application, Clinical Immunology, 2014, 155, 1, 79

    CrossRef

  7. 7
    C. Zhang, C. Li, S. Jia, P. Yao, Q. Yang, Y. Zhang, High-Mobility Group Box 1 Inhibition Alleviates Lupus-Like Disease in BXSB Mice, Scandinavian Journal of Immunology, 2014, 79, 5
  8. 8
    Yanxia Wang, Lei Zhang, Ping Wei, Huailiang Zhang, Cuijie Liu, Inhibition of PI3Kδ Improves Systemic Lupus in Mice, Inflammation, 2014, 37, 3, 978

    CrossRef

  9. 9
    Zev Sthoeger, Amir Sharabi, Edna Mozes, Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus, Journal of Autoimmunity, 2014, 54, 60

    CrossRef

  10. 10
    Manuel F. Ugarte-Gil, Graciela S Alarcón, Systemic lupus erythematosus: a therapeutic challenge for the XXI century, Clinical Rheumatology, 2014, 33, 4, 441

    CrossRef

  11. 11
    Mark G. Kirchhof, Jan P. Dutz, The Immunopathology of Cutaneous Lupus Erythematosus, Rheumatic Disease Clinics of North America, 2014, 40, 3, 455

    CrossRef

  12. 12
    Dandan Wang, Jing Li, Yu Zhang, Miaojia Zhang, Jinyun Chen, Xia Li, Xiang Hu, Shu Jiang, Songtao Shi, Lingyun Sun, Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study, Arthritis Research & Therapy, 2014, 16, 2, R79

    CrossRef

  13. 13
    Chi Chiu Mok, Update on B-cell targeted therapies for systemic lupus erythematosus, Expert Opinion on Biological Therapy, 2014, 14, 6, 773

    CrossRef

  14. 14
    Pamela MK Lutalo, David P D’Cruz, Update on belimumab for the management of systemic lupus erythematosus, Expert Opinion on Biological Therapy, 2014, 14, 11, 1701

    CrossRef

  15. 15
    I. Ferreira, D. Isenberg, Vaccines and biologics, Annals of the Rheumatic Diseases, 2014, 73, 8, 1446

    CrossRef

  16. 16
    Brian A. Baldo, A worldwide yearly survey of new data in adverse drug reactions, 2014,

    CrossRef

  17. 17
    Laurens P. Kil, Rudi W. Hendriks, Aberrant B Cell Selection and Activation in Systemic Lupus Erythematosus, International Reviews of Immunology, 2013, 32, 4, 445

    CrossRef

  18. 18
    Cloé Comarmond, Patrice Cacoub, Antiphospholipid syndrome: From pathogenesis to novel immunomodulatory therapies, Autoimmunity Reviews, 2013, 12, 7, 752

    CrossRef

  19. 19
    Bevra Hannahs Hahn, Belimumab for Systemic Lupus Erythematosus, New England Journal of Medicine, 2013, 368, 16, 1528

    CrossRef

  20. 20
    Moncef Zouali, Eugene A. Uy, Belimumab Therapy in Systemic Lupus Erythematosus, BioDrugs, 2013, 27, 3, 225

    CrossRef

  21. 21
    Wendy W. Cai, Michele Fiscella, Cecil Chen, Z. John Zhong, William W. Freimuth, David C. Subich, Bioavailability, Pharmacokinetics, and Safety of Belimumab Administered Subcutaneously in Healthy Subjects, Clinical Pharmacology in Drug Development, 2013, 2, 4
  22. 22
    Ronald F. van Vollenhoven, Ioannis Parodis, Adrian Levitsky, Biologics in SLE: Towards new approaches, Best Practice & Research Clinical Rheumatology, 2013, 27, 3, 341

    CrossRef

  23. 23
    Ronald F. van Vollenhoven, Challenges and opportunities in SLE clinical trials, Current Opinion in Rheumatology, 2013, 25, 5, 606

    CrossRef

  24. 24
    Jaime Calvo-Alén, Lucía Silva-Fernández, Eduardo Úcar-Angulo, José María Pego-Reigosa, Alejandro Olivé, Carmen Martínez-Fernández, Víctor Martínez-Taboada, José Luis Marenco, Estíbaliz Loza, Javier López-Longo, Juan Jesús Gómez-Reino, María Galindo-Izquierdo, Antonio Fernández-Nebro, María José Cuadrado, María Ángeles Aguirre-Zamorano, Antonio Zea-Mendoza, Íñigo Rúa-Figueroa, Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en el lupus eritematoso sistémico, Reumatología Clínica, 2013, 9, 5, 281

    CrossRef

  25. 25
    M. Ramos-Casals, G. Ruiz-Irastorza, J. Jiménez-Alonso, M.A. Khamashta, Recomendaciones sobre el uso de belimumab en el lupus eritematoso sistémico. Guía de Práctica Clínica GEAS-SEMI, Revista Clínica Española, 2013, 213, 1, 42

    CrossRef

  26. 26
    Jaime Calvo-Alén, Lucía Silva-Fernández, Eduardo Úcar-Angulo, José María Pego-Reigosa, Alejandro Olivé, Carmen Martínez-Fernández, Víctor Martínez-Taboada, José Luis Marenco, Estíbaliz Loza, Javier López-Longo, Juan Jesús Gómez-Reino, María Galindo-Izquierdo, Antonio Fernández-Nebro, María José Cuadrado, María Ángeles Aguirre-Zamorano, Antonio Zea-Mendoza, Íñigo Rúa-Figueroa, SER Consensus Statement on the Use of Biologic Therapy for Systemic Lupus Erythematosus, Reumatología Clínica (English Edition), 2013, 9, 5, 281

    CrossRef

  27. 27
    Daniel J. Wallace, Ten Developments in the Use of Biologicals for Systemic Lupus Erythematosus, Current Rheumatology Reports, 2013, 15, 7

    CrossRef

  28. 28
    Guillermo Ruiz-Irastorza, Alvaro Danza, Munther Khamashta, Tratamiento del lupus eritematoso sistémico: mitos, certezas y dudas, Medicina Clínica, 2013, 141, 12, 533

    CrossRef

  29. 29
    Emily D. Privette, Victoria P. Werth, Update on pathogenesis and treatment of CLE, Current Opinion in Rheumatology, 2013, 25, 5, 584

    CrossRef

  30. 30
    D. Bessis, Quoi de neuf en médecine interne ?, Annales de Dermatologie et de Vénéréologie, 2012, 139, S194

    CrossRef

  31. 31
    Pamela M. K Lutalo, Natasha Jordan, Thi-Sau Migone, David P. D'Cruz, Belimumab (Benlysta®),